Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1978 Aug;37(4):321–327. doi: 10.1136/ard.37.4.321

Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA).

A Gaudreau, B Amor, M F Kahn, A Ryckewaert, J Sany, A P Peltier
PMCID: PMC1000237  PMID: 308354

Abstract

Clinical and biological manifestations have been studied in 134 patients whose serum had antibodies to soluble extractable nuclear antigens (ENA). 85 of the patients had anti-RNP antibodies, 18 had anti-Sm antibodies, and 31 had antibodies to one or more soluble nuclear antigen. In all groups, the predominant clinical manifestations were polyarthritis, Raynaud's phenomenon, fever, and skin involvement. Renal disease was less common in those patients with anti-RNP antibodies than in the other patients. Most patients with definite renal disease (13 out of 15) also had circulating anti-DNA antibodies. The final diagnoses in these 134 patients were well defined connective tissue disease in 59; overlap syndromes in 34; a limited clinical syndrome made up of polyarthritis Raynaud's phenomenon--often with swollen fingers--and/or hypergammaglobulin-aemia in 31, and various other clinical conditions in 10.

Full text

PDF
321

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akizuki M., Powers R., Holman H. R. A soluble acidic protein of the cell nucleus which reacts with serum from patients with systemic lupus erythermatosus and Sjögren's syndrome. J Clin Invest. 1977 Feb;59(2):264–272. doi: 10.1172/JCI108637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alspaugh M. A., Tan E. M. Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest. 1975 May;55(5):1067–1073. doi: 10.1172/JCI108007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Appelboom T., Kahn M. F., Peltier A. P., de SEZE S. Rhumatisme dysimmunitaire du syndrome de Raynaud (rhumatisme inflammatoire, syndrome de Raynaud, facteurs antinucleaires mouchetés et anticorps antiribonuclopréteine): une nouvelle entité? Ann Med Interne (Paris) 1974 Nov;125(11):841–848. [PubMed] [Google Scholar]
  4. Dubois E. L., Chandor S., Friou G. J., Bischel M. Progressive systemic sclerosis (PSS) and localized scleroderma (morphea) with positive LE cell test and unusual systemic manifesstations compatible with systemic lupus erythematous (SLE): presentation of 14 cases including one set of identical twins, one with scleroderma dn the other with SLE. Review of the literature. Medicine (Baltimore) 1971 May;50(3):199–222. doi: 10.1097/00005792-197105000-00003. [DOI] [PubMed] [Google Scholar]
  5. Farber S. J., Bole G. G. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients. Arch Intern Med. 1976 Apr;136(4):425–431. [PubMed] [Google Scholar]
  6. HOLMAN H. R., DEICHER H. R., KUNKEL H. G. The L. E. cell and the L. E. serum factors. Bull N Y Acad Med. 1959 Jul;35(7):409–418. [PMC free article] [PubMed] [Google Scholar]
  7. Koffler D., Carr R., Agnello V., Thoburn R., Kunkel H. G. Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease. J Exp Med. 1971 Jul 1;134(1):294–312. doi: 10.1084/jem.134.1.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Leibfarth J. H., Persellin R. H. Characteristics of patients with serum antibodies to extractable nuclear antigens. Arthritis Rheum. 1976 Sep-Oct;19(5):851–856. doi: 10.1002/art.1780190503. [DOI] [PubMed] [Google Scholar]
  9. Mattioli M., Reichlin M. Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera. J Immunol. 1971 Nov;107(5):1281–1290. [PubMed] [Google Scholar]
  10. Morris A. D., Littleton C., Corman L. C., Esterly J., Sharp G. C. Extractable nuclear antigen effect on the DNA anti-DNA reaction and NZB/NZW mouse nephritis. J Clin Invest. 1975 May;55(5):903–907. doi: 10.1172/JCI108018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Notman D. D., Kurata N., Tan E. M. Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med. 1975 Oct;83(4):464–469. doi: 10.7326/0003-4819-83-4-464. [DOI] [PubMed] [Google Scholar]
  12. Osnos M. C., Cyna L., Haim T., Peltier A. P., Kahn M. F., Ryckewaert A. Anticorps anti-acide désoxyribonucléique: comparaison des résultats fournis par trois méthodes de recherche. Rev Rhum Mal Osteoartic. 1977 Feb;44(2):73–78. [PubMed] [Google Scholar]
  13. Parker M. D. Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease. J Lab Clin Med. 1973 Nov;82(5):769–775. [PubMed] [Google Scholar]
  14. Peltier A. P., Aussel C., Haim T., Cyna L. Ribonucleoprotein (RNP) soluble nuclear antigen: demonstration of its reaction with serum antibodies by counter-immunoelectrophoresis and further partial characterization. J Immunol Methods. 1977;16(2):153–163. doi: 10.1016/0022-1759(77)90050-3. [DOI] [PubMed] [Google Scholar]
  15. Peltier A. P., Hughes G. R., Kahn M. F., Haim T. Détection des anticorps anti-acide désoxyribonucléique du sérum par la méthode radio-immunologique de Farr. Nouv Presse Med. 1974 Mar 16;3(11):649–653. [PubMed] [Google Scholar]
  16. Reichlin M., Mattioli M. Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. N Engl J Med. 1972 Apr 27;286(17):908–911. doi: 10.1056/NEJM197204272861702. [DOI] [PubMed] [Google Scholar]
  17. Sharp G. C., Irvin W. S., May C. M., Holman H. R., McDuffie F. C., Hess E. V., Schmid F. R. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med. 1976 Nov 18;295(21):1149–1154. doi: 10.1056/NEJM197611182952101. [DOI] [PubMed] [Google Scholar]
  18. Sharp G. C., Irvin W. S., Tan E. M., Gould R. G., Holman H. R. Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972 Feb;52(2):148–159. doi: 10.1016/0002-9343(72)90064-2. [DOI] [PubMed] [Google Scholar]
  19. Sharp G. C. Mixed connective tissue disease. Bull Rheum Dis. 1974;25(9):828–831. [PubMed] [Google Scholar]
  20. TUFFANELLI D. L., WINKELMANN R. K. Systemic scleroderma, A clinical study of 727 cases. Arch Dermatol. 1961 Sep;84:359–371. doi: 10.1001/archderm.1961.01580150005001. [DOI] [PubMed] [Google Scholar]
  21. Tan E. M. Relationship of nuclear staining patterns with precipitating antibodies in systemic lupus erythematosus. J Lab Clin Med. 1967 Nov;70(5):800–812. [PubMed] [Google Scholar]
  22. Wolfe J. F., Adelstein E., Sharp G. C. Antinuclear antibody with distinct specificity for polymyositis. J Clin Invest. 1977 Jan;59(1):176–178. doi: 10.1172/JCI108616. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES